Phase 2 HR+/HER2- Breast Cancer trials recruiting now

All HR+/HER2- Breast Cancer trials, every phase

Other phases for HR+/HER2- Breast Cancer

Phase 2 HR+/HER2- Breast Cancer trials

• Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
  NCT07581834 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
  NCT06874933 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 3 locations
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
  NCT06611813 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 11 locations
• ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
  NCT06998407 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer
  NCT06967103 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
  NCT07558733 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer
  NCT06860529 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of AVZO-021 in Patients With Advanced Solid Tumors
  NCT05867251 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.